Press Releases from Hunan Huateng Pharmaceutical Co., Ltd. (12 total)
Huateng Pharma Introduces New Cosmetic Actives to Meet Growing Demand for High-P …
Huateng Pharma, a global leader in specialty chemicals, has expanded its product portfolio to include a new line of high-quality cosmetic ingredients. The launch addresses…
Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine …
Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to…
Huateng Pharma to Showcase Extensive PEG Derivatives and CDMO Capabilities at CP …
Changsha, China - 18 March 2025 - Hunan Huateng Pharmaceutical Co., Ltd., a global leader in PEG derivatives and CDMO services for APIs and intermediates,…
Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval
Changsha, China - Hunan Huateng Pharmaceutical Co., Ltd. (Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to…
Huateng Pharma to Exhibit at CPhI Milan 2024
Huateng Pharma, a leading supplier of PEG derivatives and trusted CDMO partner, is thrilled to announce its participation in CPhI Worldwide 2024, scheduled for October…
Huateng Pharma Expands CDMO Services in Veterinary APIs, Pharmaceutical Intermed …
Huateng Pharma, a leading Contract Development and Manufacturing Organization (CDMO), is proud to announce the expansion of its specialized services in Veterinary APIs, Pharmaceutical Intermediates,…
Huateng Pharma Introduces Y-Shape PEG NHS
Changsha, China, July 22, 2024 - Huateng Pharma, a global leader in PEG derivatives and a premier CDMO for APIs and intermediates, is excited to…
Huateng Pharma Launches New Innovative Product: Piroctone Olamine
Huateng Pharma, a leading Contract Development and Manufacturing Organization (CDMO), is proud to announce the launch of its latest product, Piroctone Olamine (CAS: 68890-66-4). This…
Huateng Pharma Proudly Unveils Its New Product - Semaglutide Side Chains
Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain. This groundbreaking addition to Huateng Pharma's esteemed portfolio…
Huateng Pharma's Featured Product Line: Veterinary API and Intermediates
Huateng Pharma, a Contract Development and Manufacturing Organization (CDMO) specializing in APIs and intermediates, is proud to announce its featured product line catering specifically to…
Huateng Pharma Unveils Cutting-Edge Gastrointestinal API Intermediates
Huateng Pharma, a renowned name in the pharmaceutical industry, is proud to introduce a groundbreaking addition to its product portfolio - Gastrointestinal API Intermediates. This…
Huateng Pharma Develops Anti-virus Spray Against COVID-19
China's resumption of work and production is in full swing, and how to effectively prevent the spread of COVID-19 is particularly important now. Since the…
Go To Page:
